Jian Luo
MD
Postdoctoral Scientist
Type-2 cellular immunity in asthma
Recent publications
-
IL-5 antagonism reverses priming and activation of eosinophils in severe eosinophilic asthma.
Journal article
Luo J. et al, (2024), Mucosal immunology
-
Group 3 innate lymphoid cells secret neutrophil chemoattractants and are insensitive to glucocorticoid via aberrant GR phosphorylation.
Journal article
He LX. et al, (2023), Respir Res, 24
-
Key Principles for Conducting a Good Randomized Controlled Trial.
Journal article
Luo J., (2022), Respiratory care, 67, 1211 - 1213
-
Pre-existing asthma as a comorbidity does not modify cytokine responses and severity of COVID-19
Journal article
Luo J. et al, (2021), Allergy, Asthma & Clinical Immunology, 17
-
Efficacy and safety of antagonists for chemoattractant receptor-homologous molecule expressed on Th2 cells in adult patients with asthma: a meta-analysis and systematic review.
Journal article
Yang J. et al, (2018), Respiratory research, 19